News
Is Abbott Laboratories Still a Good Dividend Stock to Buy?
When it rains, it pours. After several weeks of relative quiet, dividend-paying healthcare businesses are reporting quarterly results left and right. Unfortunately, not everyone is telling stories
2 Ultra-High-Yield Dividend Stocks You'll Regret Not Buying at These Prices
Incentives matter on Wall Street, and far too often the wrong incentives get insiders paid at the expense of investors. But sometimes you can find situations where the interests of shareholders and
Nasdaq Bear Market: 5 Terrific Growth Stocks You'll Regret Not Buying on the Dip
There's a very good chance that when 2022 comes to a close, it'll be remembered as one of the most difficult years in history for professional and everyday investors. The first half of the year saw
Social Security Is About to Do Something It's Only Done 3 Times Before
Although Social Security has been around for a really long time, the program tends to evolve from year to year. One change seniors have come to expect is their annual cost-of-living adjustment, or
The Controversial Way Social Security Can Generate $775 Billion in Revenue Over the Next Decade
For many Americans, Social Security already is, or will become, an important part of their monthly income during retirement. According to annual surveys conducted by Gallup over the past two
Why Novavax Stock Rose 12.57% on Friday
Vaccine maker Novavax (NASDAQ: NVAX) saw its shares jump 12.57% on Friday. The stock closed at $17.18 on Thursday and opened at $17.27 on Friday. It climbed to as high as $19.46 before closing at
Hurricane Season Is Almost Over – In New Orleans And On Wall Street
For weekend reading, Gary Alexander, senior writer at Navellier & Associates, offers the following commentary:
The Hurricane Season Is Coming To An End
The official “hurricane season” runs six
Why Moderna Stock Rallied Today
Shares of Moderna (NASDAQ: MRNA) jumped 8.4% on Friday after rival drugmaker Pfizer (NYSE: PFE) said it intends to drastically increase the price of its COVID-19 vaccine next year.
Pfizer is seeking
My Top Industrial Stock to Buy in October
There are variations on the theme here, but one of the most provocative sayings on Wall Street is that you should buy when there's blood on the Street. That's definitely the case today with
Why Ally Financial Stock Dropped 10.2% This Week
Ally Financial (NYSE: ALLY) saw its stock price fall 10.2% this week on third-quarter earnings that did not meet analysts' expectations. The stock price stood at $29.25 per share at the market close
3 Top Stocks to Buy if There Is a Market Pull-back
As the market pulls back in fits and starts, a normal pattern in a bear market, investors should have a wish list of companies that they want to buy at lower prices. Three good dividend names to
Why Meta Platforms, Roku, and Pinterest Stocks Crashed Friday Morning
Snap (NYSE: SNAP) released disappointing financial results after the market close on Thursday, reporting that advertisers are reining in spending as a result of the rapidly deteriorating economic
Where Will Adobe Stock Be in 1 Year?
Adobe's (NASDAQ: ADBE) stock rose slightly on Oct. 19 after the company revealed its guidance for fiscal 2023, which starts in early December. Let's review those new estimates and see if they'll
Why Tango Therapeutics Shares Rose 39.7% This Week
Shares of Tango Therapeutics (NASDAQ: TNGX), a biotech company that specializes in target cancer therapies, rose 39.7% this week, according to data from S&P Global Intelligence. The stock closed at
Is It Time To Snack On Mondelez Stock?
- Mondelez is the world’s #1 biscuit company and #2 chocolate maker
- Snacks and candies are a durable business in both economic booms and recessions
- The Clif Bar acquisition complements its snack
Why Schlumberger Led Energy Stocks Higher Today
Friday was a good day for the broad market, but a great one for oil and gas stocks. Schlumberger Limited (NYSE: SLB) ended today's session up 10.3% following an encouraging third-quarter earnings
Why Huntington Bancshares' Stock Rose Today
Shares of Huntington Bancshares (NASDAQ: HBAN) gained nearly 9.5% today after the large regional bank reported third-quarter earnings results.
Huntington reported earnings per common share of $0.39
Why We Need To Talk About Money And How To Get Started
A few years ago, I was out on a hike with my friend when she asked me a question: “Are you on track to have enough money in your 401(k) by the time you are in your mid-50s to retire when you are
American Express Beats Earnings & Revenue Views, Raises Guidance
- American Express profit came in at $2.47 per share, ahead of expectations for $2.40 per share. Revenue was $13.6 billion, also beating views.
- The company cited growth in goods and services
1 Eye-Popping Figure EV investors Need to See
The move to electric vehicles (EV) has been happening slowly for many reasons. One of the points of friction has been the lack of charging infrastructure. But there's one eye-popping number and a
1 Growth Stock Down 78% That Could Drop Further: Here's Why It's a Buy Anyway
The market is still experiencing a downturn. When will it bottom out? It's nearly impossible to predict. Moreover, investors shouldn't focus on trying to time the market. Although stocks might fall
This Growth Stock Just Hit a New 52-Week High and Still Has Room to Grow
The economy has all the earmarks of heading toward recession, and the stock market indices that had been going up in recent days are turning down once more. Both the S&P 500 and Nasdaq Composite
Snap Stock Falls As User Growth Slows To Single-Digits
- Snap’s third quarter revenue came in at $1.13 billion, compared to 1.14 billion projected.
- Daily Active Users (DAU) increased to 363 million.
- Snap continues to struggle as restructuring costs, and
Why Verizon Stock Dropped Today
Shares of Verizon (NYSE: VZ) fell 4.5% on Friday, as investors grew increasingly concerned about the wireless giant's waning customer growth.
Verizon's revenue rose 4% year over year to $34.2
Dark Day For Talaris Therapeutics Sees The Stock Dive 44% After Trial Patient Fatality
Discusses the event and how it unfolded with market commentary
It was a dark day of trading on Thursday for biopharma Talaris Therapeutics Inc (NASDAQ:TALS) after management reported a fatality of